Skip to main content
ALHCAlignment Healthcare, Inc.Sell6.1·$21.69+0.14%
ALHC · Concentration risk · 10-K extracted

Alignment Healthcare (ALHC) concentration risks

Updated

The most significant concentration Alignment Healthcare discloses is CMS contracts, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Alignment Healthcare’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH1
MEDIUM1
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-in & outside partyCustomer

CMS contracts

10-K Item 1: 'We currently derive substantially all of our revenue from CMS contracts related to our Medicare Advantage health plans.'
SEC 10-K · filed Feb 2026
MEDIUMBuilt-inGeographic

limited number of U.S. states

10-K Item 1A: 'Our plans are concentrated in a limited number of U.S. states and we may not be able to establish new geographic presences.'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

Alignment Healthcare's disclosed concentration profile is defined by two reinforcing exposures — one on the revenue side and one geographic — that together describe a business whose entire financial model depends on a single payer category concentrated in a limited number of states. On the revenue side, the company derives substantially all of its revenue from CMS contracts related to its Medicare Advantage health plans. By disclosed size this is a high-share exposure, and its character is mixed: it combines the structural reality of operating in a federally funded managed care model with the dependency risk that comes from having CMS as the effectively exclusive source of revenue. Any change in Medicare Advantage reimbursement rates, program rules, or policy priorities at CMS is not a partial headwind but a direct hit to the entire revenue base. Layered on top is a geographic concentration: the company's plans are concentrated in a limited number of U.S. states and the filing acknowledges the risk of not being able to establish new geographic presences. This is a moderate-share structural exposure by disclosed size, but it compounds the CMS dependency — if adverse regulatory or competitive conditions arise in any of the few states where plans operate, there is limited offset from a diversified footprint. Together these two exposures mean the company's results are concentrated both by payer (CMS) and by geography, creating a relatively narrow risk perimeter. Tracking Medicare Advantage policy developments and the company's ability to expand its geographic footprint are the two most important variables for assessing how this profile evolves.

For the engine’s reasoning on ALHC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Healthcare Plans

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
ALHCAlignment Healthcare, Inc.1102
CNCCentene Corporation1023
CIThe Cigna Group0505
ELVElevance Health, Inc.0202
CVSCVS Health Corporation0011
HUMHumana Inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks ALHC Concentration risk